Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000152608 | SCV000201905 | likely benign | not specified | 2015-07-30 | criteria provided, single submitter | clinical testing | p.Arg1948Arg in Exon 29 of USH2A: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wit hin the splice consensus sequence, and has been identified in 25/ 66592 of Europ ean (Non-Finnish) chromosomes by the Exome Aggregation Consortium (ExAC, http:// exac.broadinstitute.org/; dbSNP rs147930567). |
Counsyl | RCV000664977 | SCV000789023 | likely benign | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2016-12-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000841270 | SCV000983229 | likely benign | not provided | 2020-03-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000841270 | SCV001068268 | benign | not provided | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000841270 | SCV004125615 | likely benign | not provided | 2023-07-01 | criteria provided, single submitter | clinical testing | USH2A: BP4, BP7 |
Genome- |
RCV003453133 | SCV004181753 | benign | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001826817 | SCV004181754 | benign | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001826817 | SCV002091558 | likely benign | Usher syndrome type 2A | 2019-12-08 | no assertion criteria provided | clinical testing |